Alcon is trading up 4.06% at $66.46 on October 15; available market coverage points to investors favoring defensive healthcare stocks as technology shares sold off after hotter inflation data. - Strong earnings from major industry peers have also supported healthcare. - Recent analyst target reductions are company-specific but do not explain the rise. - Current trading volume is unconfirmed, so activity levels cannot be assessed.